Preliminary Recommendation for the Inclusion of Insulin Glargine and Insulin Detemir for Type 1 and Type 2 Diabetes Mellitus in the PNF

Link to the Evidence Summary: Evidence Summary on insulin glargine and detemir for type 1 and type 2 diabetes mellitus

Link to appeals form here:  https://hta.doh.gov.ph/topic-nomination/

(stakeholders may submit appeals to hta@doh.gov.ph until 11 August 2022.)